These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29078745)

  • 1. Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history.
    Zhu YO; Aw PPK; de Sessions PF; Hong S; See LX; Hong LZ; Wilm A; Li CH; Hue S; Lim SG; Nagarajan N; Burkholder WF; Hibberd M
    BMC Genomics; 2017 Oct; 18(1):829. PubMed ID: 29078745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation.
    Betz-Stablein BD; Töpfer A; Littlejohn M; Yuen L; Colledge D; Sozzi V; Angus P; Thompson A; Revill P; Beerenwinkel N; Warner N; Luciani F
    J Virol; 2016 Aug; 90(16):7171-7183. PubMed ID: 27252524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
    Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA
    J Viral Hepat; 2014 Nov; 21(11):809-17. PubMed ID: 24329944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evolution of hepatitis B virus quasispecies during lamivudine-entecavir sequential therapy].
    Liu L; Tang YZ; Li JG; Zhou JJ; Wang XH; Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):423-7. PubMed ID: 20587311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convergence and coevolution of hepatitis B virus drug resistance.
    Thai H; Campo DS; Lara J; Dimitrova Z; Ramachandran S; Xia G; Ganova-Raeva L; Teo CG; Lok A; Khudyakov Y
    Nat Commun; 2012 Apr; 3():789. PubMed ID: 22510694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
    Allen MI; Deslauriers M; Andrews CW; Tipples GA; Walters KA; Tyrrell DL; Brown N; Condreay LD
    Hepatology; 1998 Jun; 27(6):1670-7. PubMed ID: 9620341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in viral loads of lamivudine-resistant mutants and evolution of HBV sequences during adefovir dipivoxil therapy.
    Suzuki F; Kumada H; Nakamura H
    J Med Virol; 2006 Aug; 78(8):1025-34. PubMed ID: 16789011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy.
    Chen L; Zhang Q; Yu DM; Wan MB; Zhang XX
    J Hepatol; 2009 May; 50(5):895-905. PubMed ID: 19304333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and application of a genechip method for detection of hepatitis B virus lamivudine-resistant mutants and basal core promotor/Pre-C mutants].
    Li B; Zhou BP; Peng JF; Chen LY; Zhang W; Tang W; Wang ZQ; Yin ZH; Xu LM; Luo RL; Li XH; Liu SY
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):309-12. PubMed ID: 20108783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
    Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
    J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
    Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
    J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.
    Mendes-Correa MC; Pinho JR; Locarnini S; Yuen L; Sitnik R; Santana RA; Gomes-Gouvêa MS; Leite OM; Martins LG; Silva MH; Gianini RJ; Uip DE
    J Med Virol; 2010 Sep; 82(9):1481-8. PubMed ID: 20648600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of an oligonucleotide ligation assay to detect lamivudine resistance in hepatitis B virus.
    Beck IA; Payant R; Ngo-Giang-Huong N; Khamduang W; Laomanit L; Jourdain G; Frenkel LM
    J Virol Methods; 2016 Jul; 233():51-5. PubMed ID: 27025356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment.
    Moriconi F; Colombatto P; Coco B; Ciccorossi P; Oliveri F; Flichman D; Maina AM; Sacco R; Bonino F; Brunetto MR
    J Antimicrob Chemother; 2007 Aug; 60(2):341-9. PubMed ID: 17567633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of lamivudine-resistant hepatitis B virus (HBV) strains with and without breakthrough hepatitis in patients with chronic hepatitis B evaluated by serial HBV full-genome sequences.
    Horiike N; Duong TN; Michitaka K; Joko K; Hiasa Y; Konishi I; Yano M; Onji M
    J Med Virol; 2007 Jul; 79(7):911-8. PubMed ID: 17516520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
    Kim KH; Lee KH; Chang HY; Ahn SH; Tong S; Yoon YJ; Seong BL; Kim SI; Han KH
    J Med Virol; 2003 Nov; 71(3):367-75. PubMed ID: 12966541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
    Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
    J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing.
    Ko SY; Oh HB; Park CW; Lee HC; Lee JE
    Clin Microbiol Infect; 2012 Oct; 18(10):E404-11. PubMed ID: 22757653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.